HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Morgan Petronelli, Managing Editor

Contemporary OB/GYN

Morgan Petronelli is managing editor of Contemporary OB/GYN® and Contemporary Pediatrics® and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining the Contemporary brands. You can reach her at mpetronelli@mjhlifesciences.com.

Articles

How to navigate vulvar dermatology

September 30, 2022

Knowing what is normal and abnormal with the vulvovaginal area is crucial for accurate diagnosis, according to a presentation at the 25th Annual Premier Women's Healthcare Conference held in Houston, Texas.

The future of ibrexafungerp for prevention of recurrent yeast infections

September 09, 2022

Nkechi Azie, MD, MBA, FIDSA, vice president of clinical development and medical affairs at SCYNEXIS, discusses the potential FDA approval of ibrexafungerp (Brexafemme; SCYNEXIS) for the prevention of recurrent vulvovaginal candidiasis.

Pap Talk: March of Dimes launches new preterm birth research center at UCSF

August 31, 2022

Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.

March of Dimes launches new preterm birth research center at UCSF

August 24, 2022

Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.

FDA approves generic cetrorelix acetate injection

August 19, 2022

The FDA has approved cetrorelix acetate for injection, a generic version of Cetrotide, for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian stimulation.